1453526
USP
Naltrexone Related Compound A
United States Pharmacopeia (USP) Reference Standard
Synonym(s):
(5α)-17-(3-Butenyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one hydrochloride, N-(3-Butenyl)noroxymorphone hydrochloride, NIH 10458
About This Item
Recommended Products
grade
pharmaceutical primary standard
API family
naltrexone
manufacturer/tradename
USP
drug control
USDEA Schedule II; regulated under CDSA - not available from Sigma-Aldrich Canada
application(s)
pharmaceutical (small molecule)
format
neat
InChI
1S/C20H23NO4.ClH/c1-2-3-9-21-10-8-19-16-12-4-5-13(22)17(16)25-18(19)14(23)6-7-20(19,24)15(21)11-12;/h2,4-5,15,18,22,24H,1,3,6-11H2;1H/t15-,18+,19+,20-;/m1./s1
InChI key
UMLGCEOOYPDDJJ-ITLPAZOVSA-N
General description
For further information and support please go to the website of the issuing Pharmacopoeia.
Application
- Naltrexone Hydrochloride
- Naltrexone Hydrochloride Tablets
Analysis Note
Other Notes
related product
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral - STOT SE 3
target_organs
Central nervous system
Storage Class
11 - Combustible Solids
wgk_germany
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Certificates of Analysis (COA)
Sorry, we don't have COAs for this product available online at this time.
If you need assistance, please contact Customer Support.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service